← Back to Clinical Trials
Recruiting NCT07261735

NCT07261735 Clinical Evaluation of Customized Attachment Composites in Clear Aligner Therapy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07261735
Status Recruiting
Phase —
Sponsor Saglik Bilimleri Universitesi
Condition Clear Aligner Therapy
Study Type OBSERVATIONAL
Enrollment 24 participants
Start Date 2025-08-25
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
GC G-ænial A'Chord Universal CompositeSpectra ST HV (High Viscosity)Spectra ST LV (Low Viscosity)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 24 participants in total. It began in 2025-08-25 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective observational clinical study aims to evaluate the three-dimensional surface wear and clinical survival of orthodontic attachments fabricated with customized composite materials used in clear aligner therapy. Attachments play a critical role in the biomechanical efficiency of aligner treatment by facilitating planned tooth movements. However, the mechanical and surface properties of the composites used for attachment fabrication may affect their wear behavior and long-term stability. In this study, four different composite materials will be tested using a split-mouth design in patients treated with clear aligners. Each quadrant will receive a different composite, including both customized and universal types. All attachments will be fabricated using standardized digital templates and bonded under identical clinical conditions. Surface wear will be evaluated using three-dimensional optical scanning and metrology software at baseline, 1 week, 1 month, 3 months, and 6 months. Lost attachments will be replaced and recorded but excluded from wear analysis. The results of this study are expected to provide valuable insights into the optimal material selection for clear aligner attachments, improving treatment accuracy and clinical durability.

Eligibility Criteria

Inclusion Criteria: * Fully erupted permanent dentition. * No existing prosthetic restorations. * Mild-to-moderate dental crowding or spacing (2-6 mm). * Patients who are scheduled to undergo clear aligner therapy at the Department of Orthodontics, Gülhane Faculty of Dentistry, between 01.08.2025 and 01.08.2026. * Patients who agree to participate and provide informed consent. Exclusion Criteria: * History of previous fixed orthodontic treatment. * Patients with poor predicted compliance or low cooperation. * Presence of severe or generalized periodontal disease. * High caries incidence or untreated caries. * Poor oral hygiene * Habitual consumption of hard foods. * Bruxism * Congenitally missing permanent teeth. * Dental developmental anomalies. * Teeth with existing composite resin restorations or ceramic crowns on buccal surfaces (which may interfere with attachment bonding or wear analysis)

Contact & Investigator

Central Contact

Gizem Boztaş Demir, Asst. Prof.

✉ gizem.demir@sbu.edu.tr

📞 +905331518464

Frequently Asked Questions

Who can join the NCT07261735 clinical trial?

This trial is open to participants of all sexes, studying Clear Aligner Therapy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07261735 currently recruiting?

Yes, NCT07261735 is actively recruiting participants. Contact the research team at gizem.demir@sbu.edu.tr for enrollment information.

Where is the NCT07261735 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07261735 clinical trial?

NCT07261735 is sponsored by Saglik Bilimleri Universitesi. The trial plans to enroll 24 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology